马文斌;王裕;王樑;王雅宁;代从新;邱晓光;赵炳昊;
MA Wen-bin;Glioma Committee of the Gerontology Section of Chinese Medical Doctor Association;Department of Neurosurgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;

• 1:中国医师协会脑胶质瘤专委会老年胶质瘤学组
• 2:中国医学科学院北京协和医学院北京协和医院神经外科
• 3:中国医学科学院北京协和医院
• 4:中国人民解放军空军军医大学唐都医院

摘要(Abstract)：

胶质瘤是成年人中最常见的原发性脑肿瘤,其中以胶质母细胞瘤(glioblastoma,GBM)恶性程度最高。目前针对胶质瘤患者的治疗方式主要包括手术切除、放疗和化疗,而GBM的治疗策略,特别是老年GBM患者的治疗策略,尤其是手术方式,常因其自身特点而产生差异。术前系统而全面的评估有助于总结老年GBM的临床特点及相应诊疗方案,为临床医生提供更全面的患者信息,以更加准确判断老年患者对手术的耐受程度以及预测患者预后。本专家共识在对最新研究证据进行系统回顾的基础上,将目前已广泛应用的胶质瘤术前评估项目及评估工具进行总结,初步建立中国老年胶质瘤患者术前评估体系。
Glioma is the most common primary brain tumor in adults,among which glioblastoma( GBM) is the most malignant. At present,the therapeutic regimen for patients with glioma mainly includes surgery,radiotherapy,and chemotherapy. However,the treatment strategy for elderly patients with GBM often varies because of their characteristics. A systematic and comprehensive assessment before the operation will be helpful to summarize clinical characteristics of elderly patients with GBM,and can provide clinicians with more comprehensive clinical information in order to evaluate the patient's tolerance to surgery and predict the prognosis. Based on a systematic review of the latest research,this expert consensus summarizes the most widely used and studied tools of preoperative assessment of glioma,and initially establishes a preoperative evaluation system for elderly patients with glioma in China.

关键词(KeyWords)： 胶质瘤;术前评估;老年
glioma;preoperative assessment;geriatric

Abstract:

Keywords:

基金项目(Foundation): 中国医学科学院医学与健康科技创新工程(2016-I2M-2-001)

作者(Authors): 马文斌;王裕;王樑;王雅宁;代从新;邱晓光;赵炳昊;
MA Wen-bin;Glioma Committee of the Gerontology Section of Chinese Medical Doctor Association;Department of Neurosurgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;

参考文献(References)：

• [1]Ostrom QT,Gittleman H,Xu J,et al.CBTRUS Statistical Report:Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013[J].Neuro Oncol,2016,18:v1-v75.
• [2]国家卫生健康委员会医政医管局.脑胶质瘤诊疗规范(2018年版)[J].中华神经外科杂志,2019,35:217-239.
• [3]Almenawer SA,Badhiwala JH,Alhazzani W,et al.Biopsy versus partial versus gross total resection in older patients with high-grade glioma:a systematic review and metaanalysis[J].Neuro Oncol,2015,17:868-881.
• [4]Extermann M,Hurria A.Comprehensive geriatric assessment for older patients with cancer[J].J Clin Oncol,2007,25:1824-1831.
• [5]Martinez R,Janka M,Soldner F,et al.Gross-total resection of malignant gliomas in elderly patients:implications in survival[J].Zentralbl Neurochir,2007,68:176-181.
• [6]Vuorinen V,Hinkka S,Farkkila M,et al.Debulking or biopsy of malignant glioma in elderly people-a randomised study[J].Acta Neurochir(Wien),2003,145:5-10.
• [7]Gupta N,Goumnerova LC,Manley P,et al.Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma[J].Neuro Oncol,2018,20:1547-1555.
• [8]Kellermann SG,Hamisch CA,Ruess D,et al.Stereotactic biopsy in elderly patients:risk assessment and impact on treatment decision[J].J Neurooncol,2017,134:303-307.
• [9]Tanaka S,Meyer FB,Buckner JC,et al.Presentation,management,and outcome of newly diagnosed glioblastoma in elderly patients[J].J Neurosurg,2013,118:786-798.
• [10]Mohile SG,Dale W,Somerfield MR,et al.Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy:ASCO Guideline for Geriatric Oncology[J].J Clin Oncol,2018,36:2326-2347.
• [11]Soubeyran P,Bellera C,Goyard J,et al.Screening for vulnerability in older cancer patients:the ONCODAGE Prospective Multicenter Cohort Study[J].PLoS One,2014,9:e115060.
• [12]Overcash JA,Beckstead J,Extermann M,et al.The abbreviated comprehensive geriatric assessment(aCGA):a retrospective analysis[J].Crit Rev Oncol Hematol,2005,54:129-136.
• [13]Saliba D,Elliott M,Rubenstein LZ,et al.The Vulnerable Elders Survey:a tool for identifying vulnerable older people in the community[J].J Am Geriatr Soc,2001,49:1691-1699.
• [14]Kim JW,Kim SH,Lee YG,et al.Prospective Validation of The Korean Cancer Study Group Geriatric Score(KG)-7,a Novel Geriatric Screening Tool,in Older Patients with Advanced Cancer Undergoing First-line Palliative Chemotherapy[J].Cancer Res Treat,2019.doi:10.4143/crt.2018.451.[Epub ahead of print].
• [15]Rowbottom L,Loucks A,Jin R,et al.Performance of the Vulnerable Elders Survey 13 screening tool in identifying cancer treatment modification after geriatric assessment in pre-treatment patients:A retrospective analysis[J].JGeriatr Oncol,2019,10:229-234.
• [16]Perry JR,Laperriere N,O'Callaghan CJ,et al.Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma[J].N Engl J Med,2017,376:1027-1037.
• [17]Johnson DR,Sawyer AM,Meyers CA,et al.Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma[J].Neuro Oncol,2012,14:808-816.
• [18]Hansson L,Lithell H,Skoog I,et al.Study on COgnition and Prognosis in the Elderly(SCOPE):baseline characteristics[J].Blood Press,2000,9:146-151.
• [19]Nasreddine ZS,Phillips NA,Bedirian V,et al.The Montreal Cognitive Assessment,MoCA:a brief screening tool for mild cognitive impairment[J].J Am Geriatr Soc,2005,53:695-699.
• [20]Rambeau A,Beauplet B,Laviec H,et al.Prospective comparison of the Montreal Cognitive Assessment(MoCA)and the Mini Mental State Examination(MMSE)in geriatric oncology[J].J Geriatr Oncol,2019,10:235-240.
• [21]Fiorentino A,Caivano R,Chiumento C,et al.Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma[J].Med Oncol,2012,29:3467-3471.
• [22]Ening G,Osterheld F,Capper D,et al.Charlson comorbidity index:an additional prognostic parameter for preoperative glioblastoma patient stratification[J].J Cancer Res Clin Oncol,2015,141:1131-1137.
• [23]Villani V,Tanzilli A,Telera SM,et al.Comorbidities in elderly patients with glioblastoma:a field-practice study[J].Future Oncol,2019,15:841-850.
• [24]Cloney M,D'Amico R,Lebovic J,et al.Frailty in Geriatric Glioblastoma Patients:A Predictor of Operative Morbidity and Outcome[J].World Neurosurg,2016,89:362-367.
• [25]Basic D,Shanley C.Frailty in an older inpatient population:using the clinical frailty scale to predict patient outcomes[J].J Aging Health,2015,27:670-685.
• [26]Peters KB,West MJ,Hornsby WE,et al.Impact of healthrelated quality of life and fatigue on survival of recurrent high-grade glioma patients[J].J Neurooncol,2014,120:499-506.
• [27]Aaronson NK,Ahmedzai S,Bergman B,et al.The European Organization for Research and Treatment of Cancer QLQ-C30:a quality-of-life instrument for use in international clinical trials in oncology[J].J Natl Cancer Inst,1993,85:365-376.
• [28]Aapro M,Extermann M,Repetto L.Evaluation of the elderly with cancer[J].Ann Oncol,2000,11 Suppl 3:223-229.
• [29]Jager-Wittenaar H,Dijkstra PU,Vissink A,et al.Malnutrition in patients treated for oral or oropharyngeal cancerprevalence and relationship with oral symptoms:an explorative study[J].Support Care Cancer,2011,19:1675-1683.
• [30]Gielda BT,Mehta P,Khan A,et al.Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival[J].Int J Radiat Oncol Biol Phys,2011,81:985-991.
• [31]李璞,赵理.南阳市敬老院230例老人营养状况调查[J].中国老年学杂志,2004,24:747-748.
• [32]周丽平,孙建萍,杨支兰,等.养老机构老年人营养管理研究进展[J].中国老年学杂志,2016,36:753-755.
• [33]Rubenstein LZ,Harker JO,Salva A,et al.Screening for undernutrition in geriatric practice:developing the short-form mini-nutritional assessment(MNA-SF)[J].J Gerontol ABiol Sci Med Sci,2001,56:M366-M372.
• [34]Guigoz Y,Lauque S,Vellas BJ.Identifying the elderly at risk for malnutrition.The Mini Nutritional Assessment[J].Clin Geriatr Med,2002,18:737-757.
• [35]Kristensen SD,Knuuti J,Saraste A,et al.2014 ESC/ESAGuidelines on non-cardiac surgery:cardiovascular assessment and management:The Joint Task Force on non-cardiac surgery:cardiovascular assessment and management of the European Society of Cardiology(ESC)and the European Society of Anaesthesiology(ESA)[J].Eur Heart J,2014,35:2383-2431.
• [36]Fleisher LA,Fleischmann KE,Auerbach AD,et al.2014ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines[J].J Am Coll Cardiol,2014,64:e77-e137.
• [37]朱鸣雷,黄宇光,刘晓红,等.老年患者围手术期管理北京协和医院专家共识[J].协和医学杂志,2018,9:36-41.
• [38]Kaya T,Sipahi S,Karacaer C,et al.Evaluation of nutritional status with different methods in geriatric hemodialysis patients:impact of gender[J].Int Urol Nephrol,2014,46:2385-2391.
• [39]Lin MY,Liu WY,Tolan AM,et al.Preoperative serum albumin but not prealbumin is an excellent predictor of postoperative complications and mortality in patients with gastrointestinal cancer[J].Am Surg,2011,77:1286-1289.
• [40]Fujii T,Sutoh T,Morita H,et al.Serum albumin is superior to prealbumin for predicting short-term recurrence in patients with operable colorectal cancer[J].Nutr Cancer,2012,64:1169-1173.
• [41]Han S,Li Z,Master LM,et al.Exogenous IGFBP-2 promotes proliferation,invasion,and chemoresistance to temozolomide in glioma cells via the integrin beta1-ERK pathway[J].Br J Cancer,2014,111:1400-1409.
• [42]Borg N,Guilfoyle MR,Greenberg DC,et al.Serum albumin and survival in glioblastoma multiforme[J].J Neurooncol,2011,105:77-81.
• [43]Schwartzbaum JA,Lal P,Evanoff W,et al.Presurgical serum albumin levels predict survival time from glioblastoma multiforme[J].J Neurooncol,1999,43:35-41.
• [44]Perisanidis C,Psyrri A,Cohen EE,et al.Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors:A systematic review and meta-analysis[J].Cancer Treat Rev,2015,41:960-970.
• [45]Zhao J,Zhao M,Jin B,et al.Tumor response and survival in patients with advanced non-small-cell lung cancer:the predictive value of chemotherapy-induced changes in fibrinogen[J].BMC Cancer,2012,12:330.
• [46]Pichler M,Hutterer GC,Stojakovic T,et al.High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific,metastasis-free,as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients[J].Br J Cancer,2013,109:1123-1129.
• [47]Wen J,Yang Y,Ye F,et al.The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment[J].Breast,2015,24:745-750.
• [48]Matsuda S,Takeuchi H,Kawakubo H,et al.Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy:comparison with the Glasgow prognostic score[J].Ann Surg Oncol,2015,22:302-310.
• [49]He ZQ,Duan H,Ke C,et al.Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed highgrade gliomas[J].Oncotarget,2017,8:49605-49614.
• [50]Han LH,Jia YB,Song QX,et al.Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma[J].Asian Pac J Cancer Prev,2015,16:2245-2250.
• [51]Guthrie GJ,Charles KA,Roxburgh CS,et al.The systemic inflammation-based neutrophil-lymphocyte ratio:experience in patients with cancer[J].Crit Rev Oncol Hematol,2013,88:218-230.
• [52]Zitvogel L,Tesniere A,Kroemer G.Cancer despite immunosurveillance:immunoselection and immunosubversion[J].Nat Rev Immunol,2006,6:715-727.
• [53]Inouye SK,Studenski S,Tinetti ME,et al.Geriatric syndromes:clinical,research,and policy implications of a core geriatric concept[J].J Am Geriatr Soc,2007,55:780-791.
• [54]Kane RL,Shamliyan T,Talley K,et al.The association between geriatric syndromes and survival[J].J Am Geriatr Soc,2012,60:896-904.
• [55]Vallet-Regi M,Manzano M,Rodriguez-Manas L,et al.Management of Cancer in the Older Age Person:An Approach to Complex Medical Decisions[J].Oncologist,2017,22:335-342.
• [56]Svendsboe E,Terum T,Testad I,et al.Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer's disease[J].Int J Geriatr Psychiatry,2016,31:1075-1083.
• [57]Balducci L,Extermann M.Management of cancer in the older person:a practical approach[J].Oncologist,2000,5:224-237.